Infex Therapeutics

Chester, United Kingdom

Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.

$5.8M raised

May 2026

Venture - Series Unknown

Clinical Trials Manufacturing Therapeutics

Top Investors

GM&C Life Sciences Fund PACE-AMR Jon Moulton

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Infex Therapeutics

How much funding has Infex Therapeutics raised?

Infex Therapeutics has raised $5.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.

Who are Infex Therapeutics's investors?

Infex Therapeutics's investors include GM&C Life Sciences Fund, PACE-AMR, Jon Moulton.

Where is Infex Therapeutics headquartered?

Infex Therapeutics is headquartered in Chester, United Kingdom.

What does Infex Therapeutics do?

Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.

What stage is Infex Therapeutics at?

Infex Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 12, 2026.

MLA

"Infex Therapeutics — Funding & Investors." VCBacked, May 12, 2026, https://www.vcbacked.co/company/infex-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2026). Infex Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/infex-therapeutics

Wikipedia (cite web)

{{cite web |title=Infex Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/infex-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 12, 2026.

Similar Companies in Clinical Trials